Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Prion-like mechanisms in neurodegenerative diseases.

Frost B, Diamond MI.

Nat Rev Neurosci. 2010 Mar;11(3):155-9. doi: 10.1038/nrn2786. Epub 2009 Dec 23. Review.

2.

The expanding realm of prion phenomena in neurodegenerative disease.

Frost B, Diamond MI.

Prion. 2009 Apr-Jun;3(2):74-7. Epub 2009 Apr 16. Review.

3.

Prion-like propagation of protein aggregation and related therapeutic strategies.

Kaufman SK, Diamond MI.

Neurotherapeutics. 2013 Jul;10(3):371-82. doi: 10.1007/s13311-013-0196-3. Review.

4.

Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.

Goedert M, Falcon B, Clavaguera F, Tolnay M.

Curr Neurol Neurosci Rep. 2014 Nov;14(11):495. doi: 10.1007/s11910-014-0495-z. Review.

PMID:
25218483
5.

[The role of proteins in neurodegenerative disease].

Szwed A, Miłowska K.

Postepy Hig Med Dosw (Online). 2012 Apr 16;66:187-95. Review. Polish.

6.

[Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].

Yoshida K, Higuchi K, Ikeda S.

Brain Nerve. 2012 Jun;64(6):665-74. Review. Japanese.

PMID:
22647474
7.

Mouse models for studying the formation and propagation of prions.

Watts JC, Prusiner SB.

J Biol Chem. 2014 Jul 18;289(29):19841-9. doi: 10.1074/jbc.R114.550707. Epub 2014 May 23. Review.

8.

The propagation of prion-like protein inclusions in neurodegenerative diseases.

Goedert M, Clavaguera F, Tolnay M.

Trends Neurosci. 2010 Jul;33(7):317-25. doi: 10.1016/j.tins.2010.04.003. Epub 2010 May 20. Review.

PMID:
20493564
9.

The role of crowded physiological environments in prion and prion-like protein aggregation.

Ma Q, Hu JY, Chen J, Liang Y.

Int J Mol Sci. 2013 Oct 25;14(11):21339-52. doi: 10.3390/ijms141121339. Review.

10.

Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Jucker M, Walker LC.

Nature. 2013 Sep 5;501(7465):45-51. doi: 10.1038/nature12481. Review.

11.

Prion-like Mechanisms in Alzheimer's Disease.

Yin RH, Tan L, Jiang T, Yu JT.

Curr Alzheimer Res. 2014;11(8):755-64. Review.

PMID:
25212914
12.

Prions: generation and spread versus neurotoxicity.

Halliday M, Radford H, Mallucci GR.

J Biol Chem. 2014 Jul 18;289(29):19862-8. doi: 10.1074/jbc.R114.568477. Epub 2014 May 23. Review.

13.

Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.

Walker LC.

Annu Rev Genet. 2016 Nov 23;50:329-346. Review.

PMID:
27893962
14.
15.

Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.

Holmes BB, Diamond MI.

J Biol Chem. 2014 Jul 18;289(29):19855-61. doi: 10.1074/jbc.R114.549295. Epub 2014 May 23. Review.

16.

Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.

Hong L, Simon JD.

Metallomics. 2011 Mar;3(3):262-6. doi: 10.1039/c0mt00052c. Epub 2010 Nov 29. Review.

PMID:
21116546
17.

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics.

Kovacs GG, Botond G, Budka H.

Acta Neuropathol. 2010 Apr;119(4):389-408. doi: 10.1007/s00401-010-0658-1. Epub 2010 Mar 3. Review.

PMID:
20198481
18.

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

Jellinger KA.

ScientificWorldJournal. 2011;11:1893-907. doi: 10.1100/2011/371893. Epub 2011 Oct 24. Review.

19.

Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.

Goedert M, Masuda-Suzukake M, Falcon B.

Brain. 2017 Feb;140(2):266-278. doi: 10.1093/brain/aww230. Epub 2016 Sep 21. Review.

PMID:
27658420
20.

[The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].

Tarutani A, Hisanaga SI, Hasegawa M.

Brain Nerve. 2016 Oct;68(10):1197-1204. Review. Japanese.

PMID:
27703107

Supplemental Content

Support Center